Health ❯ Healthcare ❯ Medical Devices

Continuous Glucose Monitoring

DexCom, Inc. Abbott Lingo Dexcom Stelo FreeStyle Libre DexCom Regulatory Compliance

Carillon Q3 Mid-Cap Growth Letter Highlights AI-Fueled Rally, Value’s Edge, and Three Pivotal Stock Updates

The firm frames the quarter as a rally driven by AI enthusiasm plus expected rate cuts.

DexCom Investors Face Late-December Deadlines in Suits Over FDA-Flagged CGM Changes

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes